31748578|t|Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice.
31748578|a|Mounting evidence suggests that antiretroviral therapy (ART) drugs may contribute to the prevalence of HIV-associated neurological dysfunction. The HIV envelope glycoprotein (gp120) is neurotoxic and has been linked to alterations in mitochondrial function and increased inflammatory gene expression, which are common neuropathological findings in HIV+ cases on ART with neurological disorders. Tenofovir disproxil fumarate (TDF) has been shown to affect neurogenesis in brains of mice and mitochondria in neurons. In this study, we hypothesized that TDF contributes to neurotoxicity by modulating mitochondrial biogenesis and inflammatory pathways. TDF administered to wild-type (wt) and GFAP-gp120 transgenic (tg) mice caused peripheral neuropathy, as indicated by nerve conduction slowing and thermal hyperalgesia. Conversely TDF protected gp120-tg mice from cognitive dysfunction. In the brains of wt and gp120-tg mice, TDF decreased expression of mitochondrial transcription factor A (TFAM). However, double immunolabelling revealed that TFAM was reduced in neurons and increased in astroglia in the hippocampi of TDF-treated wt and gp120-tg mice. TDF also increased expression of GFAP and decreased expression of IBA1 in the wt and gp120-tg mice. TDF increased tumor necrosis factor (TNF) alpha in wt mice. However, TDF reduced interleukin (IL) 1beta and TNFalpha mRNA in gp120-tg mouse brains. Primary human astroglia were exposed to increasing doses of TDF for 24 hours and then analyzed for mitochondrial alterations and inflammatory gene expression. In astroglia, TDF caused a dose-dependent increase in oxygen consumption rate, extracellular acidification rate and spare respiratory capacity, changes consistent with increased metabolism. TDF also reduced IL-1beta-mediated increases in IL-1beta and TNFalpha mRNA. These data demonstrate that TDF causes peripheral neuropathy in mice and alterations in inflammatory signaling and mitochondrial activity in the brain.
31748578	0	29	Tenofovir disoproxil fumarate	Chemical	MESH:D000068698
31748578	38	59	peripheral neuropathy	Disease	MESH:D010523
31748578	71	83	inflammation	Disease	MESH:D007249
31748578	130	134	mice	Species	10090
31748578	239	242	HIV	Disease	MESH:D015658
31748578	254	278	neurological dysfunction	Disease	MESH:D009461
31748578	284	287	HIV	Species	11676
31748578	288	309	envelope glycoprotein	Gene	17276
31748578	321	331	neurotoxic	Disease	MESH:D020258
31748578	407	419	inflammatory	Disease	MESH:D007249
31748578	484	487	HIV	Species	11676
31748578	507	529	neurological disorders	Disease	MESH:D009461
31748578	531	559	Tenofovir disproxil fumarate	Chemical	-
31748578	561	564	TDF	Chemical	-
31748578	617	621	mice	Species	10090
31748578	687	690	TDF	Chemical	-
31748578	706	719	neurotoxicity	Disease	MESH:D020258
31748578	763	775	inflammatory	Disease	MESH:D007249
31748578	786	789	TDF	Chemical	-
31748578	825	829	GFAP	Gene	14580
31748578	852	856	mice	Species	10090
31748578	864	885	peripheral neuropathy	Disease	MESH:D010523
31748578	932	952	thermal hyperalgesia	Disease	MESH:D006930
31748578	965	968	TDF	Chemical	-
31748578	988	992	mice	Species	10090
31748578	998	1019	cognitive dysfunction	Disease	MESH:D003072
31748578	1054	1058	mice	Species	10090
31748578	1060	1063	TDF	Chemical	-
31748578	1126	1130	TFAM	Gene	21780
31748578	1179	1183	TFAM	Gene	21780
31748578	1255	1258	TDF	Chemical	-
31748578	1283	1287	mice	Species	10090
31748578	1289	1292	TDF	Chemical	-
31748578	1322	1326	GFAP	Gene	14580
31748578	1355	1359	IBA1	Gene	114737
31748578	1383	1387	mice	Species	10090
31748578	1389	1392	TDF	Chemical	-
31748578	1403	1436	tumor necrosis factor (TNF) alpha	Gene	21926
31748578	1443	1447	mice	Species	10090
31748578	1458	1461	TDF	Chemical	-
31748578	1470	1492	interleukin (IL) 1beta	Gene	16176
31748578	1497	1505	TNFalpha	Gene	21926
31748578	1523	1528	mouse	Species	10090
31748578	1545	1550	human	Species	9606
31748578	1597	1600	TDF	Chemical	-
31748578	1636	1661	mitochondrial alterations	Disease	MESH:D028361
31748578	1666	1678	inflammatory	Disease	MESH:D007249
31748578	1710	1713	TDF	Chemical	-
31748578	1750	1756	oxygen	Chemical	MESH:D010100
31748578	1886	1889	TDF	Chemical	-
31748578	1903	1911	IL-1beta	Gene	16176
31748578	1934	1942	IL-1beta	Gene	16176
31748578	1947	1955	TNFalpha	Gene	21926
31748578	1990	1993	TDF	Chemical	-
31748578	2001	2022	peripheral neuropathy	Disease	MESH:D010523
31748578	2026	2030	mice	Species	10090
31748578	2050	2062	inflammatory	Disease	MESH:D007249
31748578	Positive_Correlation	MESH:D009461	16176
31748578	Positive_Correlation	16176	17276
31748578	Positive_Correlation	MESH:D010100	16176
31748578	Positive_Correlation	MESH:D015658	16176
31748578	Positive_Correlation	MESH:D006930	16176
31748578	Positive_Correlation	MESH:D000068698	MESH:D010523
31748578	Positive_Correlation	MESH:D007249	16176
31748578	Positive_Correlation	MESH:D000068698	16176
31748578	Positive_Correlation	114737	16176
31748578	Positive_Correlation	MESH:D028361	16176
31748578	Association	MESH:D000068698	MESH:D007249
31748578	Association	MESH:D020258	17276
31748578	Positive_Correlation	16176	21926
31748578	Positive_Correlation	MESH:D010523	16176
31748578	Association	MESH:D007249	17276
31748578	Positive_Correlation	MESH:D020258	16176
31748578	Positive_Correlation	14580	16176
31748578	Positive_Correlation	MESH:D003072	16176
31748578	Positive_Correlation	16176	21780

